311
Views
11
CrossRef citations to date
0
Altmetric
Review

Evaluation of the efficacy of randomized controlled trials of sensory stimulation interventions for sleeping disturbances in patients with dementia: a systematic review

&
Pages 543-548 | Published online: 17 Mar 2017

Abstract

Objective

The current review aims to evaluate the sensory stimulation interventions in terms of reducing sleeping disturbances in patients with dementia. The nonpharmacological interventions seem to be an efficient, inexpensive, and easy tool for family caregivers. Moreover, sleeping disorders increase caregivers’ distress and may lead to hospitalization.

Methods

A systematic literature search was performed. Eleven randomized controlled trials have been found. Among these eleven trials, one referred to massage therapy and acupuncture, and the other ten studies referred to bright light therapy.

Results

The results demonstrated that there are no relevant randomized controlled trials of music therapy, aromatherapy, and multisensory environment/Snoezelen referring to sleeping disturbances. Several studies have been conducted about the effect of the bright light therapy, and there is also another study that combines massage therapy and acupuncture therapy.

Conclusion

Sensory stimulation interventions are inexpensive and practical for dementia caregivers; however, only bright light therapy seems to be useful to reduce sleeping problems in dementia. The other sensory stimulation interventions lack evidence, and there is a strong need for further research.

Introduction

Dementia is a chronic, progressive, devastating disorder, which in early stages is characterized by cognitive problems. In addition, dementia influences the behavior of the patient, causing behavioral and psychological problems, also known as behavioral and psychological symptoms in dementia (BPSD).Citation1 The most common BPSD are psychosis, aggression, depression, anxiety, euphoria, apathy, abnormal motor behavior, disinhibition, agitation, sleeping disturbances, and eating disorders.Citation2

Sleeping disorder is a common symptom in dementia, especially in Alzheimer’s disease (AD), Lewy body dementia (LBD), and Parkinson’s disease dementia (PDD). Specifically, 44% of patients with dementia (PwD) suffer from sleeping disturbances.Citation3 Sleeping problem is a very vital problem not only for the patient but also for the caregiver. It causes significant distress and precipitates institutionalization.Citation4 The most common sleeping disorders of PwD are the difficulty in falling asleep, the patient may wander or be involved in inappropriate activities during the night, getting up during the night, waking up at night and act like it is morning, being awake too early in the morning, sleeping excessively during the day, and having nightmares.Citation5 Therefore, sleeping disturbances affect sleep duration and sleep quality.

The economic impact of dementia is astounding. The annual cost is expected to surpass 1 trillion dollars in 2050, and the estimated number of PwD will reach ~65.7 million people by 2030 and 115.4 million by 2050.Citation6 Furthermore, the pharmacological treatment of sleeping disturbances still needs further research. There have been several trials that examined the effectiveness of melatonin in sleeping problems in dementia.Citation7Citation10 The trials confirm a strong evidence of melatonin in combination with a sensory stimulation intervention and bright light therapy (BLT).Citation11 However, the effect of melatonin itself on treating sleeping disorders in dementia needs further research. Additionally, the impact of cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) seems limited.Citation3 Likewise, it is also a common phenomenon to use sedative–hypnotics and second-generation antipsychotics in order to treat sleeping disorders in dementia.Citation12 However, these drugs often cause significant side effects to the patients, and therefore, they should be avoided, as possible.Citation13 Benzodiazepines are another drug category that is used extensively to treat sleeping disorders. However, it is worth to mention that recent trials have found that benzodiazepines cause cognitive decline, disorientation, memory problems, and risk of falls.Citation14 Therefore, it seems that there is a strong need of finding effective nonpharmacological interventions. The nonpharmacological interventions known till now can be summarized into four major categories:Citation15 1) cognitive/emotion-oriented interventions (reminiscence therapy, simulated presence therapy, reality orientation, validation therapy, and cognitive stimulation therapy), 2) sensory stimulation interventions (music therapy, aromatherapy, BLT, massage therapy, multisensory stimulation therapy, and acupuncture), 3) behavior management techniques (Montessori theory, low noise, decreased sensory stimulation, and caregiver’s education), and 4) other psychosocial interventions (physical exercise).

Sensory stimulation is a nonpharmacological intervention category. It refers to a variety of techniques that aim to stimulate the senses and not the cognitive part of the patient.Citation16 The notion of sensory stimulation interventions has its roots in the 1960s.Citation17 According to the philosophy of the intervention, the senses enable patients to interact effectively with the environment and communicate better with others.Citation17 In terms of dementia, sensory stimulation interventions in general have been found as effective and studied for reducing sleeping disturbances and among others agitation, depression, apathy, and anxiety symptoms. This was the reason that the current review examined them. However, one critical question that occurs is do all of the sensory stimulation interventions help dementia patients in their sleeping problems? The current review aims to address the following objective: to evaluate the efficacy of randomized controlled trials (RCTs) of sensory stimulation nonpharmacological interventions for sleeping disturbances in PwD.

Methods

Search strategy

Studies were extracted from MEDLINE, PubMed, Web of Knowledge, CINAHL, EMBASE, Cochrane Library, PsycINFO, LILACS, and SCOPUS. The search was controlled to find RCTs of sensory stimulation interventions for sleeping disturbances in PwD. For practical reasons, the search excluded papers written in any other language but English. For an overview of the search terms, refer to Box 1.

Study selection

The papers selected for this systematic review strictly met the following criteria: 1) were sensory stimulation interventions, 2) were RCTs, 3) were referring to sleeping disorders in dementia, and 4) were using the same diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorder Association (NINCDS-ADRDA). The titles and abstracts were evaluated for the preceding criteria. If the title and the abstract did not meet the criteria, then the articles were retrieved and screened.

Data extraction

The first reviewer extracted articles that matched the inclusion criteria. The studies were examined for their participant characteristics, content of the intervention, methodology, and outcomes. The two authors discussed about any disagreement on the extraction process.

Results

Study characteristics

The number of manuscripts excluded from the search were 14 studies for massage therapy, 4 studies for acupuncture, and 5 studies for BLT. We did not find any relevant study for music therapy, aromatherapy, and multisensory therapy/Snoezelen. Finally, we included 11 studies for all the sensory stimulation interventions that were referring to sleeping disturbances in PwD. Among these 11 trials, 1 referred to massage therapy and acupuncture and the other 10 studies referred to BLT.

Box 1 Systematic literature search

308 → potentially relevant articles: 47 → exclusion articles based on abstract or full text: 36 → selected articles for the review: 11

Participants

A total of 760 participants were included in the studies. All of the participants were PwD in different stages. The inclusion criteria for all the studies were 1) a clear diagnosis of dementia according to DSM-IV and NINCDS-ADRDA or ICD-10, 2) to be an RCT, 3) to refer to sensory stimulation interventions, and 4) to refer to sleeping disturbances in dementia.

The smallest sample size was 13 participantsCitation18 and the larger one was 189.Citation19 Four studies had sample sizes <25 participants.Citation18,Citation20Citation22 In addition, one trial stabilized the medication of their participants for 12 weeks.Citation22 Moreover, two other trials reported no medication treatment during the BLT intervention,Citation23,Citation24 another study did not report its plan on medicationCitation25 and in two other trials there were no changes in medication.Citation20

Finally, all of the studies included patients with AD; however, some of them also included patients with vascular dementia (VaD),Citation19Citation21,Citation26 LBD,Citation19,Citation26 and mixed dementia.Citation19,Citation20,Citation26 One study did not report the type of dementia.Citation18 The study about massage therapy and acupuncture included patients with AD, VaD, and mixed type of dementia.Citation27

Research design and methodology

Overall, this review included 10 RCTs about BLT and one RCT study about massage therapy and acupuncture.Citation27 Two studies used a single-blind crossover design,Citation20,Citation21 four studies used a single-blind design,Citation18,Citation23Citation25 one study used a double-blind design,Citation19 another one was an experimental study,Citation22 another study did not give much information about its design, except the fact that the interviews were blinded and had an independent raterCitation26 and the other two studies were RCTs.Citation27,Citation28 The shortest duration was 10 daysCitation25 and the longest was 3.5 years.Citation19

Moreover, 7 of the 10 studies about BLT used a control group that received dim/standard light.Citation18Citation21,Citation23Citation25 Most of the studies used ~10,000 lux for their interventions (from 5,000 to 10,000 lux); however, one study used only 400 lux for both their experimental and control groups.Citation28 Approximately half of the studies were conducted in the USA,Citation21Citation25,Citation28 one of them was conducted in Japan,Citation20 one in Switzerland,Citation18 one in the UK,Citation26 one in the Netherlands,Citation19 and another one in Spain.Citation27 Among the 10 studies of BLT, 4 trials did not report any significant effect of BLT on the reduction of sleeping disturbances in PwD.Citation23Citation26 The other six trials reported that BLT decreased nightmares and also increased sleep quality and duration.Citation19Citation22,Citation28 Likewise, most of the studies used a Bright Light box,Citation20,Citation21,Citation23Citation27 another study used Dawn–Dusk simulator for the first time in the literature,Citation18 another trial used the blue-green light via a cap visor22 and finally another trial used Plexiglass diffusers.Citation19

In terms of evaluating the sleep–awake activity of the participants, some studies used wrist actigraphy.Citation18Citation20,Citation22,Citation28 In addition, blind participants or seriously visually impaired patients were excluded from the trials in all the 10 studies.

Furthermore, in terms of risk of bias, it seemed that five studies reported low risk of bias.Citation18,Citation19,Citation22,Citation25,Citation28 Two studies had unclear dataCitation20,Citation21 and three studies had a high risk of bias.Citation23,Citation24,Citation26 Five studies reported positive results of BLT;Citation19Citation22,Citation25 however, one study mentioned that the follow-up did not show great changes in sleeping disturbances of the patients.Citation21 Two other trials underlined the importance of further research.Citation19,Citation26 However, three studies did not mention any significant improvement with BLT.Citation18,Citation23,Citation24 The study about massage therapy and acupuncture mentioned positive findings.Citation27 shows the characteristics of the included studies.

Table 1 Previous trials included in current review

Discussion

In this review, we aimed to provide a systematic review of the sensory stimulation interventions that seem to have an impact on sleeping disturbances of PwD. It seems that from all of the sensory stimulation interventions (music therapy, massage therapy, multisensory environment/Snoezelen, acupuncture, BLT, and aromatherapy), only three interventions (massage therapy, acupuncture, and BLT) have been studied for reducing sleeping disturbances in PwD with RCTs. The other sensory stimulation interventions have shown positive results in the reduction of agitation, aggressive behavior, apathy, and depression but have not been studied for sleeping disturbances. It seems that there is a strong need for further research.

The most efficient sensory stimulation intervention seems to be BLT. In particular, five studies reported positive results of BLT. There is also one study about massage therapy and acupuncture. BLT seems to be a promising non-pharmacological intervention for the reduction of sleeping problems. However, one crucial issue that arises is regarding the participants. First of all, 4 of the 10 studies used a small sample size (<25 participants). Moreover, most of the trials included only patients with AD. This is a critical issue because other types of dementia can cause critical sleeping problems. For instance, patients who suffer from LBD and PDD experience sleeping disturbances sometimes even before their cognitive decline. Sleeping problem in dementia is a vital reason that may lead the patient to institutionalization. Therefore, it would be essential for future studies to include patients with all the different types of dementia. Also, the trials included patients with all the different stages of the disease. That means that there is heterogeneity of the severity of the sample sizes. It would be crucial to examine if BLT intervention has the same positive impact on the mild cognitive impairment (MCI) patients, on the early stages of dementia, and the more severe stages of dementia.

Likewise, the trials used different lights for the therapy and this is an interesting aspect for the future studies, as well. Nevertheless, it seems that the Dawn–Dusk simulator exposes only 400 lux of light, which compared to the others (Sun Ray light box, Bright Light box, light via a cap visor, and Plexiglass diffusers) is really limited. Moreover, another interesting question is if the BLT intervention has also a positive impact after the intervention. Furthermore, most of the participants were residents of long-term care facilities (assisted living, specialized wards, nursing homes, and wings), and only one trial included patients who lived in the community. This is actually something important because BLT intervention seems to be rather impractical for everyday use in a home place and also seems to be expensive. Maybe for the patients who still live in their homes, it would be better to find more personalized interventions that are practical and less expensive.

Finally, it is also worth to mention some other limitations of the trials; one study did not give information about the duration of the program, and therefore its results cannot be safe. The duration of the intervention also seemed to be short (just a few weeks) in most studies. Only one trial, which also used a double-blind design and 189 participants, lasted for 3.5 years. In terms of massage therapy and acupuncture, the results seem to be promising. However, acupuncture therapy can be used only under the supervision of an expert in acupuncture, and therefore it is also not practical for patients who live in the community. However, massage therapy is an easy intervention that can be used by the family caregivers. Nevertheless, there is a strong need for further research.

Disclosure

The authors report no conflicts of interest in this work.

References

  • SorilLJJLeggettLELorenzettiDLEffective use of the built environment to manage behavioural and psychological symptoms of dementia: a systematic reviewPLoS One2014912e11542525517508
  • SampsonELWhiteNLordKLeurentBVickerstaffaSSJonesaLPain, agitation, and behavioural problems in people with dementia admitted to general hospital wards: a longitudinal cohort studyPain2015156467568325790457
  • UrrestarazuEIriarteJClinical management of sleep disturbances in Alzheimer’s disease: current and emerging strategiesNat Sci Sleep20168213326834500
  • XiaoLDWangJHeG-PDe BellisAVerbeeckJKyriazopoulosHFamily caregiver challenges in dementia care in Australia and China: a critical perspectiveBMC Geriatr201414624456381
  • CummingsJLMegaMGrayKRosenber-ThompsonSCarusiDAGornbeinJThe Neuropsychiatric InventoryNeurology1994441223087991117
  • Alzheimer’s Association2015 Alzheimer’s disease facts and figuresAlzheimers Dement201511333238425984581
  • BurkeTMMarkwaldRRChinoyEDCombination of light and melatonin time cues for phase advancing the human circadian clockSleep201336111617162424179293
  • JenwitheesukANopparatCMukdaSWongchitratPGovitrapongPMelatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathwaysInt J Mol Sci2014159168481688425247581
  • WadeAGFarmerMHarariGAdd-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trialClin Interv Aging2014994796124971004
  • GehrmanPRConnorDJMartinJLSchochatTCorey-BloomJAncoli-IsraelSMelatonin fails to improve sleep or agitation in a double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer’s diseaseAm J Geriatr Psychiatry200917216616919155748
  • Bonmati-CarrionMAArguelles-PrietoRMartinez-MadridMJProtecting the melatonin rhythm through circadian healthy light exposureInt J Mol Sci20141512234482350025526564
  • MarstonLNazarethIPetersenIWaltersKOsbornDPJPrescribing of antipsychotics in UK primary care: a cohort studyBMJ Open2014412e006135
  • GareriPSegura-GarcíaCManfrediVGLUse of atypical antipsychotics in the elderly: a clinical reviewClin Interv Aging201491363137325170260
  • ZhongGWangYZhangYZhaoYAssociation between benzodiazepine use and dementia: a meta-analysisPLoS One2015105e012783626016483
  • O’NeilMEFreemanMChristensenVTelerantRAddlemanAKansagaraDSystematic Evidence Review of Non-pharmacological Interventions for Behavioural Symptoms of DementiaWashington, DCDepartment of Veterans Affairs2011
  • LykkesletEGjengedalESkrondalTStorjordMBSensory stimulation – a way of creating mutual relations in dementia careInt J Qual Stud Health Well-being2014910
  • AyresJSensory Integration and Learning DisordersLos Angeles, CAWestern Psychological Services1972
  • GasioPFKrauchiKCajochenCDawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderlyExp Gerontol2003381–220721612543279
  • Riemersma-van der LekRFSwaabDFTwiskJHolEMHoogendijkWJGVan SomerenEJWEffect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trialJAMA2008299222642265518544724
  • MishimaKHishikawaYOkawaMRandomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer’s typeChronobiol Int19981566476549844752
  • LyketsosCGVeielLLBakerASteeleCA randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term careInt J Geriatr Psychiatry199914752052510440971
  • NowakLThe effect of timed blue-green light on sleep-wake patterns in women with Alzheimer’s diseaseDiss Abstr Int B2008696–B1154
  • DownlingGAGrafCHubbardEMLuxenbergJSLight treatment for neuropsychiatric behaviours in Alzheimer’s diseaseWest J Nurs Res200729896197517596638
  • DowlingGABurrRLVan SomerenEJMelatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s diseaseJ Am Geriatr Soc200856223924618070004
  • Ancoli-IsraelSGehrmanPMartinJLIncreased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patientsBehav Sleep Med200311223615600135
  • BurnsHAAllenHTomensonBDuignanDByrneJBright light therapy for agitation in dementia: a randomized controlled trialInt Psychogeriatr200921471172119323872
  • Rodriguez-MansillaJGonzales-Lopez-ArzaMVVarela-DonosoEMontanero-FernandezJJimenez-PalomaresMGarrido-ArdilaEMEar therapy and massage therapy in the elderly with dementia: a pilot studyJ Tradit Chin Med201333446146724187866
  • McCurrySMPikeKCVitielloMVLogsdonRGLarsonEBTeriLIncreasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer’s disease: results of a randomized, controlled trialJ Am Geriatr Soc20115981393140221797835
  • DowlingGAGrafCHubbardEMLuxenbergJSLight Treatment for Neuropsychiatric Behaviors in Alzeimer’s DiseaseWest J Nurs Res200729896197517596638